Page last updated: 2024-10-30

lamotrigine and Common Variable Immunodeficiency

lamotrigine has been researched along with Common Variable Immunodeficiency in 2 studies

Common Variable Immunodeficiency: Heterogeneous group of immunodeficiency syndromes characterized by hypogammaglobulinemia of most isotypes, variable B-cell defects, and the presence of recurrent bacterial infections.

Research Excerpts

ExcerptRelevanceReference
"Lamotrigine (LTG) is an anti-epileptic drug and mood-stabilizing agent, whose adverse effects include skin rash and dizziness."1.43Immunoglobulin A deficiency following treatment with lamotrigine. ( Hanaya, R; Kawano, Y; Maruyama, S; Okamoto, Y; Toyoshima, M, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maruyama, S1
Okamoto, Y1
Toyoshima, M1
Hanaya, R1
Kawano, Y1
Smith, J1
Fernando, T1
McGrath, N1
Ameratunga, R1

Other Studies

2 other studies available for lamotrigine and Common Variable Immunodeficiency

ArticleYear
Immunoglobulin A deficiency following treatment with lamotrigine.
    Brain & development, 2016, Volume: 38, Issue:10

    Topics: Adolescent; Anticonvulsants; Common Variable Immunodeficiency; Epilepsy; Female; Humans; IgA Deficie

2016
Lamotrigine-induced common variable immune deficiency.
    Neurology, 2004, Mar-09, Volume: 62, Issue:5

    Topics: Common Variable Immunodeficiency; Epilepsy, Generalized; Excitatory Amino Acid Antagonists; Humans;

2004